GLP-1s, Skinny Culture, and the Question Every Woman Should Ask Herself with Natalie Jill
The first time Karen Martel and Natalie Jill talked about GLP-1 medications on Midlife Conversations, the response from women was something neither of them expected. Not more questions about side effects or dosing. What flooded in was closer to relief. Women said they finally felt heard.
That response made it clear the conversation wasn't finished. In this follow-up episode, Karen and Natalie pick up where they left off — this time with the unfiltered messages from real women in the Midlife Solutions community, and a deeper dive into what actually sits underneath the judgment: the double standard that follows women when a health tool works too well, the cultural discomfort with a woman simply deciding what she does with her own body, and the more nuanced question of whether GLP-1s themselves are the problem — or whether they're simply reflecting problems we've always had.
What We Discuss in This Episode
- The real community feedback after Part 1 of the GLP-1 conversation aired
- Where the judgment around weight loss medication comes from, and why it hits harder for women
- Natalie Jill's personal story: postpartum depression, autoimmune diagnosis, and her early forties turning point
- What "living from possibility vs living from circumstance" actually means in practice
- Whether GLP-1s are driving the trend toward extreme thinness, or whether they're exposing patterns that already existed
- The type of GLP-1 user Natalie has genuine concerns about
- The unexpected parallel between GLP-1 stigma and the breast implant illness conversation
- How to tell the difference between a triggered reaction and a genuinely uninformed one
- Why midlife might be the first real opportunity women have to stop defending their health decisions
Listen to the full episode on Apple Podcasts
The Double Standard Women Face Around GLP-1 Medications
The moment a woman says "I'm using a GLP-1" in almost any online space, the conversation shifts. She is asked to justify herself in a way that almost no other health decision requires. The same communities that rally around bodily autonomy for other medical choices often go quiet — or go critical — when the choice involves losing weight with medication.
Karen and Natalie name this directly. The discomfort isn't really about the medication. It's about a woman deciding, without apology, what she wants her body to do. And that decision has always been culturally contested territory.
This doesn't mean GLP-1s are above scrutiny. Evidence matters, risks matter, individual context matters. But scrutiny applied selectively — where it arrives fastest and loudest for women who are shrinking — says more about cultural unease than it does about the science.
Natalie Jill's Story — Postpartum Depression, Autoimmunity, and the Turning Point
Most people who know Natalie Jill know her as a fitness expert and resilience coach. What they don't usually hear is the harder chapter that preceded the career: a postpartum depression she got through without adequate support, and an autoimmune condition she didn't know she had for years.
For many midlife women, Natalie's timeline will feel familiar. You push through. You perform fine. You attribute the exhaustion, the weight changes, the mood shifts to stress or aging or not trying hard enough. And then something — a test result, a diagnosis, a moment of clarity — makes you realize the story you've been telling yourself wasn't the whole picture.
In her early forties, Natalie describes hitting a wall. Not a dramatic collapse, but the kind of quiet reckoning that happens when you've been managing for so long that managing is all you know how to do. That's when she made the shift she now talks about in her work: from living in "circumstance" to living in "possibility."
Are GLP-1s Fueling Extreme Thinness — or Exposing It?
This is the part of the conversation Karen and Natalie don't sidestep. There is a visible subset of women using GLP-1 medications who appear to be pursuing extreme thinness. That's real, and it deserves honest discussion.
But Karen and Natalie push back on the conclusion that the medication is creating this. Disordered relationships with thinness predate GLP-1s. So does the cultural machinery that rewards extreme leanness in women. What GLP-1s may be doing is making an existing pattern more visible — and more achievable — for a population that previously couldn't access it.
That's worth examining carefully. It is not, Karen and Natalie argue, a reason to condemn the medication for every woman who is using it thoughtfully, under clinical guidance, to address genuine metabolic and hormonal health concerns.
The Breast Implant Illness Parallel — and Why It Matters
One of the more unexpected threads in this conversation is the comparison Natalie draws to her own experience with breast implant illness. On the surface, it's a different topic entirely. But the underlying dynamic is similar: a woman makes a personal health or body decision, something goes wrong or she changes her mind, and the response from her community is a complicated mix of judgment and projection.
What both situations share is the discomfort other people feel when a woman exercises agency over her own body — in either direction. The judgment that follows a woman who gets implants, the judgment that follows a woman who removes them, the judgment that follows a woman who takes weight loss medication, and the judgment that follows a woman who stops: all of it is worth examining as a single pattern, not separate debates.
Triggered vs. Misinformed — How to Tell the Difference
One of the more practical threads in this episode is Karen and Natalie's distinction between two very different states that can look similar from the outside: being triggered, and being genuinely misinformed.
Being triggered means the discomfort you feel about someone else's choice is really about something in you — your own history with the topic, your own unresolved feelings about your body, your own sense of what's possible for you. It feels like a strong opinion, but it's mostly emotional charge with a thin rational justification layered on top.
Being genuinely misinformed means you have factual gaps or misunderstandings about the evidence, the mechanism, or the context of a medical decision. That's a different problem with a different solution.
The two get tangled constantly in public conversations about women's health. Sorting them out — in yourself and in the spaces you participate in — matters for actually having useful conversations rather than performing ones.
Why Midlife Is Different — And Why Some Women Are Finally Done Explaining
There's something that shifts for many women in midlife. Not for everyone, and not all at once. But the accumulation of experience — of having tried the things, of having been told what to do for decades, of having finally run out of patience for being managed — produces a different relationship to outside opinion.
Karen and Natalie talk about why midlife might be the first time in a woman's life that she genuinely stops needing the explanation to land. Not because she stops caring about connection, but because she finally has enough self-knowledge to tell the difference between feedback that's worth integrating and noise that's about someone else.
If you've ever felt the specific exhaustion of defending a health choice you didn't owe anyone an explanation for — and then felt something finally give way, some internal shift where you stopped — this conversation is partly about that.
Common Questions About GLP-1 Medications for Women in Midlife
Why is there so much judgment around GLP-1 medications?
GLP-1 medications exist at the intersection of several culturally charged topics: body size, willpower, femininity, and access to medical tools. When a medication makes significant weight loss achievable for more women, it challenges long-held narratives about what weight loss requires — and for some, that feels threatening. The judgment is rarely just about the drug. It tends to be a proxy for deeper discomfort about what it means when a woman changes her body on her own terms.
Are GLP-1s appropriate for women in perimenopause or menopause?
GLP-1 receptor agonists may be appropriate for some women navigating perimenopause or menopause, particularly those experiencing insulin resistance, metabolic shifts, or significant weight changes that have not responded to diet and lifestyle modification. Appropriateness depends on individual health history, current medications, and clinical evaluation. Women should discuss their specific circumstances with a clinician experienced in midlife hormonal health before starting any GLP-1 medication.
Can GLP-1 medications contribute to disordered eating or extreme thinness?
There is legitimate concern — discussed in this episode — that a subset of users may pursue extreme weight loss through GLP-1s in ways that reflect or worsen disordered patterns. The medications suppress appetite significantly, which can be appropriate for some people and harmful for others. Women with a history of disordered eating, those already at a low body weight, or those using the medication without clinical oversight may be at greater risk. This is a reason for careful prescribing and monitoring — not a reason to dismiss the medications for women who are appropriate candidates.
What is the connection between autoimmune conditions and weight gain in midlife women?
Several autoimmune conditions — including Hashimoto's thyroiditis, lupus, and rheumatoid arthritis — are significantly more common in women and often become symptomatic or are first diagnosed during perimenopause. These conditions can directly influence metabolic function, energy levels, inflammation, and body composition. Weight changes that don't respond to standard lifestyle interventions may sometimes reflect an underlying autoimmune or thyroid condition that hasn't been diagnosed. This is one reason that thorough lab work matters before attributing midlife weight gain solely to diet or hormones.
How do I know if my reaction to someone else's GLP-1 use is about them or about me?
As discussed in this episode: if your reaction is fast, emotionally intense, and difficult to justify with specific evidence, it may be more about your own relationship to the topic than about the other person's choice. If you find yourself reaching for facts after you've already decided how you feel, that's worth noticing. Genuinely informed concern tends to feel different — more specific, more curious, less personally charged.
What is "living from possibility" and how does it apply to midlife health?
Natalie Jill uses this phrase to describe a fundamental orientation shift: instead of defining yourself by your current health challenges, symptoms, diagnoses, or limitations, you begin from a chosen vision of who you want to be and what's available to you. In a midlife health context, this means not letting a diagnosis, a number on a scale, or a hormonal transition become your entire story. It's a framework that sits alongside medical care — it doesn't replace clinical support, but it changes the internal stance you bring to it.
Do I need to explain or justify my health choices to others?
No. You may choose to — because you want connection, because education matters to you, because your relationships are worth the conversation. But obligation is a different thing. As both Karen and Natalie discuss in this episode, there's a particular kind of freedom that becomes available in midlife: the recognition that your health decisions belong to you, and the people who matter most in your life will either understand that or grow into understanding it.
About Natalie Jill
Natalie Jill is a fitness expert, mindset coach, and bestselling author who has spent more than a decade working with women on body transformation, resilience, and midlife reinvention. She is the host of the Midlife Conversations podcast and has built a large community around the idea that midlife is not a limitation but a launching point. Natalie speaks publicly about her own experience with postpartum depression, breast implant illness, and an autoimmune diagnosis that took years to identify — bringing a level of personal authenticity to conversations about women's health that goes beyond standard wellness messaging.